183 related articles for article (PubMed ID: 37086827)
1. Hydroxyapatite nanoparticles promote TLR4 agonist-mediated anti-tumor immunity through synergically enhanced macrophage polarization.
Wang R; Hua Y; Wu H; Wang J; Xiao YC; Chen X; Ao Q; Zeng Q; Zhu X; Zhang X
Acta Biomater; 2023 Jul; 164():626-640. PubMed ID: 37086827
[TBL] [Abstract][Full Text] [Related]
2. Exposure to hydroxyapatite nanoparticles enhances Toll-like receptor 4 signal transduction and overcomes endotoxin tolerance in vitro and in vivo.
Hua Y; Wu J; Wu H; Su C; Li X; Ao Q; Zeng Q; Zhu X; Zhang X
Acta Biomater; 2021 Nov; 135():650-662. PubMed ID: 34525415
[TBL] [Abstract][Full Text] [Related]
3. Aspect ratio-dependent dual-regulation of the tumor immune microenvironment against osteosarcoma by hydroxyapatite nanoparticles.
Wu H; Wang R; Li S; Chen S; Liu S; Li X; Yang X; Zeng Q; Zhou Y; Zhu X; Zhang K; Tu C; Zhang X
Acta Biomater; 2023 Oct; 170():427-441. PubMed ID: 37634831
[TBL] [Abstract][Full Text] [Related]
4. Ginseng-derived nanoparticles alter macrophage polarization to inhibit melanoma growth.
Cao M; Yan H; Han X; Weng L; Wei Q; Sun X; Lu W; Wei Q; Ye J; Cai X; Hu C; Yin X; Cao P
J Immunother Cancer; 2019 Nov; 7(1):326. PubMed ID: 31775862
[TBL] [Abstract][Full Text] [Related]
5. Hydroxyapatite nanoparticles drive the potency of Toll-like receptor 9 agonist for amplified innate and adaptive immune response.
Zeng Q; Wang R; Hua Y; Wu H; Chen X; Xiao YC; Ao Q; Zhu X; Zhang X
Nano Res; 2022; 15(10):9286-9297. PubMed ID: 35911480
[TBL] [Abstract][Full Text] [Related]
6. A Selective Reduction of Osteosarcoma by Mitochondrial Apoptosis Using Hydroxyapatite Nanoparticles.
Wu H; Liu S; Chen S; Hua Y; Li X; Zeng Q; Zhou Y; Yang X; Zhu X; Tu C; Zhang X
Int J Nanomedicine; 2022; 17():3691-3710. PubMed ID: 36046839
[TBL] [Abstract][Full Text] [Related]
7. Toll-Like Receptor Ligands and Interferon-γ Synergize for Induction of Antitumor M1 Macrophages.
Müller E; Christopoulos PF; Halder S; Lunde A; Beraki K; Speth M; Øynebråten I; Corthay A
Front Immunol; 2017; 8():1383. PubMed ID: 29123526
[TBL] [Abstract][Full Text] [Related]
8. Anemoside A3 activates TLR4-dependent M1-phenotype macrophage polarization to represses breast tumor growth and angiogenesis.
Yin L; Fan Z; Liu P; Chen L; Guan Z; Liu Y; Luo Y
Toxicol Appl Pharmacol; 2021 Dec; 432():115755. PubMed ID: 34673087
[TBL] [Abstract][Full Text] [Related]
9. Regulation of lipid-induced macrophage polarization through modulating peroxisome proliferator-activated receptor-gamma activity affects hepatic lipid metabolism via a Toll-like receptor 4/NF-κB signaling pathway.
Wu HM; Ni XX; Xu QY; Wang Q; Li XY; Hua J
J Gastroenterol Hepatol; 2020 Nov; 35(11):1998-2008. PubMed ID: 32128893
[TBL] [Abstract][Full Text] [Related]
10. Both Type I and Type II Interferons Can Activate Antitumor M1 Macrophages When Combined With TLR Stimulation.
Müller E; Speth M; Christopoulos PF; Lunde A; Avdagic A; Øynebråten I; Corthay A
Front Immunol; 2018; 9():2520. PubMed ID: 30450098
[TBL] [Abstract][Full Text] [Related]
11. MALAT1 shuttled by extracellular vesicles promotes M1 polarization of macrophages to induce acute pancreatitis via miR-181a-5p/HMGB1 axis.
Liu J; Niu Z; Zhang R; Peng Z; Wang L; Liu Z; Gao Y; Pei H; Pan L
J Cell Mol Med; 2021 Oct; 25(19):9241-9254. PubMed ID: 34448533
[TBL] [Abstract][Full Text] [Related]
12. Toll-like receptor 4 plays a key role in advanced glycation end products-induced M1 macrophage polarization.
Liu Z; Ma Y; Cui Q; Xu J; Tang Z; Wang Y; He C; Wang X
Biochem Biophys Res Commun; 2020 Oct; 531(4):602-608. PubMed ID: 32814631
[TBL] [Abstract][Full Text] [Related]
13. Glucosylation endows nanoparticles with TLR4 agonist capability to trigger macrophage polarization and augment antitumor immunity.
Liu L; Fu S; Zhu W; Cai Z; Cao Y; Huang Y; Yang L; Fu X; Jin R; Xia C; Zhang Y; Lui S; Gong Q; Song B; Wen L; Anderson JM; Ai H
Biomaterials; 2024 Jan; 304():122424. PubMed ID: 38103347
[TBL] [Abstract][Full Text] [Related]
14. IL4 receptor targeting enables nab-paclitaxel to enhance reprogramming of M2-type macrophages into M1-like phenotype via ROS-HMGB1-TLR4 axis and inhibition of tumor growth and metastasis.
Vadevoo SMP; Kang Y; Gunassekaran GR; Lee SM; Park MS; Jo DG; Kim SK; Lee H; Kim WJ; Lee B
Theranostics; 2024; 14(6):2605-2621. PubMed ID: 38646639
[No Abstract] [Full Text] [Related]
15.
Zhang W; Xu L; Zhang X; Xu J; Jin JO
Front Immunol; 2023; 14():1213467. PubMed ID: 37720226
[TBL] [Abstract][Full Text] [Related]
16. Synergistic reinforcement of immunogenic cell death and transformation of tumor-associated macrophages via an M1-type macrophage membrane-camouflaged ferrous-supply-regeneration nanoplatform.
Wang Y; Xu H; Wang D; Lu Y; Zhang Y; Cheng J; Xu X; Chen X; Li J
Acta Biomater; 2024 Jan; 174():358-371. PubMed ID: 38092253
[TBL] [Abstract][Full Text] [Related]
17. Extracellular HSP90α Induces MyD88-IRAK Complex-Associated IKKα/β-NF-κB/IRF3 and JAK2/TYK2-STAT-3 Signaling in Macrophages for Tumor-Promoting M2-Polarization.
Fan CS; Chen CC; Chen LL; Chua KV; Hung HC; Hsu JT; Huang TS
Cells; 2022 Jan; 11(2):. PubMed ID: 35053345
[TBL] [Abstract][Full Text] [Related]
18. Paclitaxel Reduces Tumor Growth by Reprogramming Tumor-Associated Macrophages to an M1 Profile in a TLR4-Dependent Manner.
Wanderley CW; Colón DF; Luiz JPM; Oliveira FF; Viacava PR; Leite CA; Pereira JA; Silva CM; Silva CR; Silva RL; Speck-Hernandez CA; Mota JM; Alves-Filho JC; Lima-Junior RC; Cunha TM; Cunha FQ
Cancer Res; 2018 Oct; 78(20):5891-5900. PubMed ID: 30104241
[TBL] [Abstract][Full Text] [Related]
19. Advanced Glycation End Products Induce Atherosclerosis via RAGE/TLR4 Signaling Mediated-M1 Macrophage Polarization-Dependent Vascular Smooth Muscle Cell Phenotypic Conversion.
Xing Y; Pan S; Zhu L; Cui Q; Tang Z; Liu Z; Liu F
Oxid Med Cell Longev; 2022; 2022():9763377. PubMed ID: 35069982
[TBL] [Abstract][Full Text] [Related]
20. Polarization of Tumor-Associated Macrophages by Nanoparticle-Loaded
Wei B; Pan J; Yuan R; Shao B; Wang Y; Guo X; Zhou S
Nano Lett; 2021 May; 21(10):4231-4240. PubMed ID: 33998789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
